[PAPPS Expert Groups. Cancer prevention recommendations: Update 2022]. [PDF]
Marzo-Castillejo M +4 more
europepmc +1 more source
La integración de la prueba de ctDNA en el análisis de EGFR en el carcinoma pulmonar no microcítico: estrategias para el laboratorio clínico. [PDF]
Fernández-Galán E, Puig-Butillé JA.
europepmc +1 more source
[From global strategy to local consultation: A future vision of physical activity in primary care]. [PDF]
Romaguera M +5 more
europepmc +1 more source
[Respiratory Disease in the Era of Big Data]. [PDF]
Prats L, Izquierdo JL.
europepmc +1 more source
Anti-PLA2R antibody reduction as a predictor of treatment response in primary membranous nephropathy: a retrospective study. [PDF]
Bashir K +6 more
europepmc +1 more source
Emerging Topics in Heart Failure: Future Perspectives. [PDF]
Oliveira MT +5 more
europepmc +1 more source
Organ allocation and transplant equity in Brazil: the hidden burden of HLA homozygosity and hypersensitization. [PDF]
Santos Júnior ACSD +4 more
europepmc +1 more source
Polygenic Risk Scores: The Next Step for Improved Risk Stratification in Coronary Artery Disease? [PDF]
Stein R +2 more
europepmc +1 more source

